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We previously reported that oxidative stress and renal
tubular damage occur in chronic hyperoxaluric rats. However,
the in vivo responses of renal epithelial cells after vitamin E
administration and their correlations with calcium oxalate
(CaOx) crystal formation have not been evaluated. Male
Wistar rats received 0.75% ethylene glycol (EG) for 7, 21, or
42 days to induce CaOx deposition (EG group). Another
group of EG-treated rats received 200 mg kg1 of vitamin E
intraperitoneally (EGþ E group) to evaluate its effect on
hyperoxaluria. Urinary electrolytes and biochemistry and
levels of lipid peroxides and enzymes were examined,
together with serum vitamin E levels. Levels of the tubular
markers, a and l glutathione S-transferase, proliferating
cell nuclear antigen (PCNA), osteopontinin (OPN), and
Tamm-Horsfall protein (THP) were also measured, and TUNEL
staining was performed to examine the viability of the
tubular epithelium. There were no significant differences
between the two age-matched controls either untreated or
given vitamin E. Compared to untreated controls, tubular cell
death was increased at all time points in EG rats with a
gradual increase in CaOx crystals, whereas the number of
PCNA-positive cells was only significantly increased on day
21. In EGþ E rats, tubular cell death was decreased compared
to the EG group, and cell proliferation was seen at all time
points, while CaOx crystal deposition was decreased, but
hyperoxaluria, urinary lipid peroxides, and enzymuria were
unaffected. Vitamin E supplement prevented the loss of OPN
and THP in renal tissues by EG and the reduction in their
levels in the urine. The beneficial effect of vitamin E in
reducing CaOx accumulation is due to attenuation of tubular
cell death and enhancement of the defensive roles of OPN
and THP.
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Nephrolithiasis involves a cascade of events including crystal
nucleation, growth, and aggregation, their retention within
the renal tubules, and their migration to the renal papillary
surfaces.1 Urine is normally protected from the above
sequence of events by crystallization inhibitors.2 Two
important macromolecules involved in inhibiting various
steps of crystal formation are osteopontin (OPN) and Tamm-
Horsfall protein (THP).3,4 However, both OPN and THP are
also major components of renal stones.3,4 This raises the
question whether these two proteins act as inhibitors or
promoters during stone formation.
Increased free radical production in the kidney and
elevated levels of urinary lipid peroxides are seen in
experimental hyperoxaluric rats.5,6 Although the role of free
radicals in the pathogenesis of kidney calcium oxalate (CaOx)
stones has not been established, studies by Thamilselvan
et al.7 and ourselves5 have suggested that, at the start of the
urolithiasis cascade, hyperoxaluria increases free radical
production in the kidney and causes renal tubular cell
damage, and that antioxidant supplementation might protect
the membrane from injury, thereby preventing stone
formation. Vitamin E deficiency is seen in idiopathic renal
stone-formers,8 and vitamin E supplementation reduces the
risk of stone formation in renal tuberculosis.9 However, the
use of antioxidant therapy to prevent renal stone formation is
not yet established and its mechanism remains obscure.
When exposed to oxalate, renal epithelial cells have
various responses. Oxalate promotes the progression of cells
from G0/G1 to S phase of the cell cycle and is therefore
thought to initiate DNA synthesis.10 Exposure to oxalate also
results in both apoptotic and necrotic cell death in renal
epithelial cells;11 this response is dependent on the concen-
tration of oxalate, which elicits apoptotic death at lower
concentrations and necrotic cell death at higher concentra-
tions.10 In normal adult tissues, a balance must be
maintained between the number of cells produced by division
and those eliminated by death.12 Extensive DNA strand
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breakage without prompt repair may cause cell death,
resulting in the detachment of tubular cells, and the
subsequent exposure of the basement membrane may be
important in the pathogenesis of kidney stones.13 Apoptosis
results in cell surface exposure of phosphatidylserine, which
has clusters of negatively charged head groups and can attract
calcium and thus act as sites for the attachment of CaOx
crystals to the cell surface.14
In order to evaluate the in vivo responses of renal
epithelial cells and their correlations with CaOx stone
formation in the chronic hyperoxaluric rat model, we
examined sequential changes in various parameters, includ-
ing hyperoxaluria, oxidative stress on the kidney, and tubular
cell proliferation and/or death in ethylene glycol (EG)-treated
male Wister rats. We also evaluated sequential changes in the
kidneys in rats co-treated with EG and a chain-breaking
antioxidant (vitamin E), and evaluated whether a single
antioxidant therapy could prevent cellular damage from
oxidative stress and, thus, prevent renal CaOx stone
formation.
RESULTS
Body data and urinary biochemistry during CaOx crystal
formation
Table 1 shows the data for the age-matched untreated control
and EG groups. There were no significant differences in body
weight and 24-h water intake, urine output, and urinary
creatinine levels at any time point in EG rats compared to the
controls. Left kidney weight showed a significant increase in
the day 42 EG rats. As expected, urinary oxalate levels at all
time points were significantly higher than in the controls, and
were associated with alkaline urine. Urinary calcium and
magnesium levels were significantly decreased, and phos-
phate levels significantly increased, in the day 42 EG rats.
Urinary citrate levels were significantly increased in the day
21 EG rats. Renal CaOx crystals were seen on day 7 and
became more prominent with time of EG treatment, the
highest score being seen on day 42 (Table 1 and Figure 1a–d).
The changes in body weight, kidney weight, 24-h water intake
and urine output, urinary pH, creatinine, calcium, phos-
phate, and citrate excretion in the EG group were prevented
by vitamin E treatment (Table 2). Urinary magnesium
excretion was increased in the day 21 EGþ E group.
Compared to E-treated controls, although urinary oxalate
levels were significantly increased in all EGþ E subgroups,
renal CaOx crystals were only seen in the day 42 group, with
a grade of 0–1 (Figure 1e–h). As shown in Figure 1i, the
Tiselius risk index was higher in rats fed with EG than in the
untreated controls, meaning a high risk of crystal formation.
However, the Tiselius risk index increase due to EG was not
affected by vitamin E supplementation (EGþ E group).
Figure 2 shows representative pictures of CaOx crystals in
urine sediments examined by polarized microscopy. Com-
pared to their corresponding controls (Figure 2a and e),
gradual crystalluria was found in both the EG (Figure 2b–d)
and EGþ E (Figure 2f–h) groups. The dry weight of urinary
sediments was also significantly increased in both EG and
EGþ E groups from day 7 to day 42 compared to the
corresponding controls (Figure 2i). A similar increase in
CaOx crystals and dry weight of urine sediments was seen in
the EG and EGþ E groups.
Enzymuria, serum vitamin E, and urinary lipid peroxides
Figure 3a shows that significant urinary N-acetyl-b-glucos-
aminidase enzymuria and increased Lactate dehydrogenase
(LDH) activity in renal tissues were seen in the EG rats at all
time points compared to the untreated controls. In the
EGþ E subgroups, vitamin E had no effect on the EG-
induced urine enzymuria, but significantly reduced the LDH
activity in kidney homogenates. As shown in Figure 3b,
serum vitamin E levels were significantly decreased at all time
points in EG rats compared to untreated controls and this
was associated with increased urinary excretion of lipid
peroxides (malondialdehyde and thiobarbituric acid-reactive
substances). In the EGþ E subgroup, vitamin E supplemen-
tation restored serum vitamin E to control levels, but did not
Table 1 | Effect of EG on body data, urinary biochemistry, and crystal deposition in experimental rats and age-matched
untreated controls
Day 7 Day 21 Day 42
Control EG Control EG Control EG
BW (g) 285.074.2 310.975.8 352.776.4 350.278.5 410.6711.5 426.1719.8
KW (g) 1.370.1 1.570.1 1.670.1 1.870.1 1.870.1 2.570.1*
Water intake (ml/24 h) 32.872.5 46.571.5 36.272.4 47.273.1 37.973.1 40.575.6
Urine output (ml/24 h) 16.472.0 15.971.4 21.471.3 26.272.7 22.672.8 28.973.5
Urine pH 6.970.1 8.070.1* 7.070.2 8.270.1* 6.970.1 8.370.2*
Urine Cr (mg/24 h) 10.672.8 7.871.7 10.973.2 7.371.7 12.773.3 9.471.5
Urine Mg (ı`mol/24 h) 37.0722.8 35.6714.5 39.1714.7 65.8715.9 40.5716.8 4.070.9*
Urine Ca (mg/24 h) 0.5170.08 0.4870.19 0.5370.12 0.5870.14 0.5170.08 0.1670.06*
Urine P (mg/24 h) 12.472.5 13.873.5 10.872.5 11.573.5 12.272.1 19.772.3*
Urine oxalate (mmol/mg Cr) 0.870.2 20.977.5* 0.770.1 27.976.6* 0.770.2 30.278.1*
Urine citrate (mg/mg Cr) 1.270.1 1.970.9 1.370.1 4.271.3* 1.270.1 2.970.8
Renal crystal (scoring system) 0 0–I 0 0–I–II 0 II–III
BW, body weight; Ca, calcium; Cr, creatinine; EG, experimental group receiving 0.75% ethylene glycol; KW, left kidney weight; Mg, magnesium; P, phosphate.
Data are the mean7s.e.m. *Po0.05 compared to the control group.
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prevent the increase in urinary excretion of malondialdehyde
and thiobarbituric acid-reactive substances.
Changes in tubular markers in situ
In control animals, a-glutathione S-transferase (aGST)-
positive cells were abundant in the proximal tubules,
and some cells located in the glomeruli were also stained
(Figure 4a). Owing to the widespread and uniform distribu-
tion of cells containing aGST, the counting of aGST-positive
cells in renal sections in each subgroup was difficult, but we
were able to determine qualitatively that, in the EG group,
the number of aGST-positive cells was unchanged on days 7
or 21 (Figure 4b and c), but decreased on day 42 (Figure 4d),
whereas, with the EGþ E group, no difference compared to
the E-treated controls (Figure 4e) was seen at any time point
(Figure 4f–h).
The anti-mGST antibody was concentrated within the
distal renal tubule cells and collecting ducts. Although the
same problem of quantification was encountered, we
qualitatively estimated the expression of mGST-positive cells
and found that, in the EG group, there was no significant
difference at day 7 or 21 days (Figure 5b and c) compared to
untreated controls (Figure 5a), but the number of mGST-
positive cells decreased on day 42 (Figure 5d). Again, vitamin
E prevented the loss of mGST-positive cells induced by EG on
day 42 (Figure 5e–h).
Detection of cell proliferation and death in situ
The degree of tubular cell proliferation was evaluated from
the number of cells with a proliferating cell nuclear antigen
(PCNA)-positive nucleus (Figure 6a–h; summarized in Figure
6i). In the day 21 EG subgroup, renal tubule cells showed a
higher proliferation (15.475.8 cells/high-power field (HPF))
than in the age-matched control or the day 7 or 42 EG
subgroups (1.770.5, 3.370.9, 2.170.8, respectively). In the
EGþ E subgroup, the number of PCNA-positive nuclei in the
kidney was higher on days 7, 21, and 42 (13.872.0,
15.171.8, 12.371.5 cells/HPF, respectively) than in the EG
groups, but there was no significant difference between the
untreated and E-treated controls (Figure 6e–i).
Using the terminal deoxynucleotidyl transferase (TdT)-
mediated dUTP in situ nick and labeling (TUNEL) method
to detect in situ apoptosis (Figure 7), the number of TUNEL-
positive cells was 43.479.0/HPF in the untreated controls
and was significantly increased in the day 7 and 21 EG
subgroups (122.475.0 and 105.278.6 cells/HPF, respec-
tively), but showed a nonsignificant decrease compared to
the controls in the day 42 EG subgroup (29.274.5 cells/HPF)
(Figure 7a–d and i). In the E-treated control rats, the number
of TUNEL-positive cells was 55.1710.6/HPF, similar to that
in the control rats without vitamin E treatment. However,
when compared to the results for the same time point in the
EG group, vitamin E significantly reduced the increase in
TUNEL-positive cells on days 7 and 21 (42.879.7 and
22.879.2/HPF, respectively); again, on day 42, there was a
nonsignificant decrease compared to the E-treated controls
(Figure 7e–i).
Evaluation of loss of tubular cells using Western blots
To strengthen the above observations, we examined protein
expression in kidney homogenates using Western blots.
Figure 8a and b show that the expression of aGST and
mGST in the day 42 EG rats was significantly decreased to
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Figure 1 | Representative micrographs of renal CaOx crystal
deposition photographed using a polarized microscopy. Left
panels: Effect of 0.75% EG in the drinking water; (a) untreated control
group, (b–d) rats treated with EG for (b) 7, (c) 21, or (d) 42 days. Right
panels: Effect of vitamin E supplementation; (e) E-treated control
group, (f–h) rats treated with EGþ E for (f) 7, (g) 21, or (h) 42 days.
Reduced from  100. The white arrows indicate CaOx crystal
deposition. (i) Statistical result for Tiselius Risk Index calculation.
*Po0.05 compared to the corresponding control group.
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46.179.4 and 39.577.1%, respectively, of that seen in
age-matched untreated controls, while expression of both at
days 7 and 21 was similar to that in controls. Vitamin E
supplementation restored the amounts of both aGST
and mGST in kidney homogenates in the day 42 EG
subgroup to control levels. PCNA expression was significantly
higher in the day 21 EG subgroup than in the untreated
controls, but not in the day 7 and 42 EG subgroups
(Figure 8c), the same trend seen by immunohistochemical
staining of PCNA (Figure 6). Vitamin E treatment had no
effect on PCNA levels at any time point. Figure 8d shows
that cytochrome c release, a marker of apoptosis, was
significantly increased in all EG subgroups when
compared to the untreated controls, but was significantly
decreased in the day 21 and 42 EGþ E subgroups to a
level lower than that in the age-matched E-treated control
group.
Changes in anticrystallization molecules induced by vitamin
E supplement
At the time-point of 42 days when severe CaOx crystal
accumulation was seen in the EG group (Table 1), the
amount of OPN and THP in the renal medulla was
reduced to 17.573.5 and 79.2712.3%, respectively, of that
in the untreated controls (Figure 9a). With vitamin E
supplement, the OPN levels returned to 46.777.2% of
control levels, while THP levels were restored completely
(109.2712.1% of control levels). There were no significant
differences in the amounts of either protein in renal tissues
between the untreated and E-treated control groups. Figure
9b shows that urinary excretion of OPN was significantly
increased to 249.6745.8% of that in untreated controls in
the day 42 EG rats and that this was reduced to only
71.9710.3% of control levels by vitamin E treatment.
Urinary THP excretion was not affected by EG, but, most
interestingly, was reduced to 48.479.1% of control levels in
the EGþ E group.
DISCUSSION
Hyperoxaluria is a major risk factor of human idiopathic
CaOx stone disease and can be experimentally induced by
chronic administration of EG as a 0.75% aqueous solution in
drinking water to male rats. Consistent with our previous
study,6 we observed that it takes approximately 9 days for
crystalluria to appear and about 14 days for crystal
deposition to start in the kidneys, maximal deposition taking
42 days. This time course is similar to that reported by
Khan.2 Oxaluria starts on day 3 and reaches a plateau around
day 7, so the hyperoxaluric effect can be studied in this
period. Severe crystalluria associated with hyperoxaluria and
nephrocalcinosis are found around day 21 to 42, suggesting
that the combined effect of crystal deposition and hyperox-
aluria can be studied during this period. Moreover, loss of
antioxidant activity and severe oxidative stress are also seen
on day 42. In the present study, we therefore choose the
prolonged period for treating EG for 42 days to study the
effect of vitamin E.
There is no denying that pH is an important factor in
CaOx formation, but we still observed CaOx crystal
deposition in the EG rats with alkaline urine. The increased
urine pH in EG rats seen in the present study is consistent
with the results of a previous study by Lee et al.15 and a study
of Itoh et al.16 in the EG model of urolithiasis. From these
results, we speculate that changes in the microenvironment
inside the kidney are primary causes of CaOx formation, but
acidic urine may favor crystal aggregation or deposition in
the urinary tract.
As regards urinary calcium, the reduced urinary excretion
of calcium seen in EG rats in the present study was similar to
that seen in previous studies (either normo- or hypo-
calciuria).2,15,17,18 As suggested by Robertson and Peacock,19
hypercalciuria may only play a secondary role in the
pathogenesis of calcium stones in man. Lee et al.15
strengthened this observation in rats fed with either a high
calcium diet or EG and showed that hypercalciuria cannot
Table 2 | Effects of EG on body data, urinary biochemistry, and crystal deposition in experimental rats and age-matched
controls treated with vitamin E
Day 7 Day 21 Day 42
E-treated controls EG+E E-treated controls EG+E E-treated controls EG+E
BW (g) 265.875.7 285.577.0 315.277.2 290.5718.6 408.2715.1 390.579.6
KW (g) 1.770.1 1.770.2 1.570.1 1.670.1 2.170.1 2.070.1
Water intake (ml/24 h) 35.577.6 56.5710.3 55.878.9 79.079.1 42.672.8 45.773.2
Urine output (ml/24 h) 22.874.1 37.975.8 31.775.8 37.272.1 29.373.4 35.771.0
Urine pH 8.4470.06 8.6770.12 8.8270.03 8.7070.10 8.7870.08 8.8170.12
Urine Cr (mg/24 h) 7.770.8 8.171.5 9.171.4 8.871.8 12.472.7 12.273.4
Urine Mg (ı`mol/24 h) 10.572.0 11.175.6 11.876.8 43.9712.4* 10.772.4 11.772.4
Urine Ca (mg/24 h) 0.5370.16 0.3770.05 0.3370.04 0.7770.05 0.5070.09 0.4870.08
Urine P (mg/24 h) 12.372.9 10.472.5 9.870.8 15.174.8 10.372.6 10.372.3
Urine oxalate (mmol/mg Cr) 0.970.2 15.472.3* 1.770.6 25.974.9* 1.570.4 34.876.5*
Urine citrate (mg/mg Cr) 1.670.7 1.470.5 1.170.5 1.570.8 1.470.6 1.370.6
Renal crystal 0 0 0 0 0 0–I
BW, body weight; Ca, calcium; Cr, creatinine; E, vitamin E treatment; EG, experimental group receiving 0.75% ethylene glycol and vitamin E; KW, left kidney weight;
Mg, magnesium; P, phosphate.
Data are the mean7s.e.m. *Po0.05 compared to the E-treated control group.
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induce CaOx stone formation in the absence of hyper-
oxaluria, implying that the urinary calcium level is sufficient
for crystal formation even when the level is lower, as in our
present study, than in normal rats. However, using vitamin D
to enhance calcium reabsorption, Halabe et al.20 showed an
increased incidence of renal stone formation. From the
above, it is difficult to conclude whether the urinary level of
calcium plays a minor role in crystal formation. Another
explanation for the lowered urinary calcium excretion is the
increased CaOx crystal deposition in both compartments of
the kidney tissue and the urinary sediment, which might
consume more calcium and cause hypocalciuria.
Although urinary magnesium on day 21 in EG rats was
high, but not statistically significant. At the same time-point
EG rats supplied with vitamin E show a significant increase in
urinary magnesium when compared to the corresponding
control. Since urinary magnesium acts as a potent inhibitor
of stone formation, we speculate that an increase in
magnesium may provide protection against other intrarenal
factors that predispose the kidney to crystal formation. For
the EG rats, the amount of CaOx crystal deposition on day 21
was not as severe as that on day 42. However, whether this
increment might provide the ability to overcome CaOx
deposition is unknown, but, in the present study, CaOx
crystals were still deposited in day 21 EG kidneys.
If we use the morphologic criteria of necrosis,11 cellular
and nuclear swelling were first noted on day 7 of EG
administration and became prominent on day 42 (Figure 4).
Necrotic cell death results in the loss of cell membrane
integrity and the subsequent leakage of cellular contents, such
as LDH, into the environment, attracting inflammatory cells
that may contribute to additional tissue damage.21 In this
study, we found that LDH activity in kidney homogenates
was significantly increased on days 7, 21, and 42 of EG
treatment. These findings are in accordance with those of our
previous study using anti-ED-1 antibody, which showed that
infiltration of macrophages/monocytes into the renal inter-
stitium increases on day 7 of EG treatment and is more
prominent on day 21, and that the cells fuse into giant cells
on day 42.6 These two sets of results show that necrotic cell
death can happen as early as at day 7 of EG treatment, at
which time only small CaOx crystals are seen in the tubular
lumen.
Apoptosis of tubular epithelial cells exposed to oxalate has
been seen in cell culture studies.11,13,22 The amount of
ceramide increases after oxalate treatment,11 but its role in
apoptosis is inconclusive. Labeling of DNA fragments is a
well accepted and widely used histological method for
detecting apoptotic cells.23 However, TUNEL staining cannot
always distinguish between apoptotic and necrotic cells and
sometimes falsely identifies cells in the process of DNA
repair.24,25 Cytochrome c is located in the inter-membrane
space of the mitochondria, but, when released into the
cytoplasm, interacts with apoptotic protease activation
factor-1 and caspase-9 to activate caspase-3.25 Thus, the
localization of cytochrome c provides an early indication of
apoptosis.25 In this study, cytochrome c release was increased
on days 7, 21, and 42 of EG treatment compared to untreated
controls, but the number of apoptosis-positive nuclei was not
increased in kidney sections in the 42-day EG group;
however, increased necrotic cell death and the loss of tissue
integrity after long-term exposure to hyperoxaluria made it
difficult to evaluate apoptotic-positive nuclei in this group.25
GST is a gene superfamily of xenobiotic-metabolizing
enzymes and consists of three classes, a, p, and m. aGST is a
cytosolic enzyme, which has been shown to be a useful
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Figure 2 | Representative micrographs of CaOx crystals in urine
sediments photographed using a polarized microscopy. Left two
bars: Effect of 0.75% EG on (a) untreated controls or (b–d) rats treated
with EG for (b) 7, (c) 21, or (d) 42 days. Right two bars: Effect of
vitamin E supplementation on (e) E-treated controls or (f–h) EG rats
treated with vitamin E for (f) 7, (g) 21, or (h) 42 days. Reduced from
 100. (i) Statistical result for the dry weight of urine sediments.
*Po0.05 compared to the corresponding control group.
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Figure 3 | Effect of vitamin E on tubular cell damage and urinary lipid peroxide excretion in the EG-treated kidneys. (a) Temporal
changes in urine enzymuria (N-acetyl-b-glucosaminidase) and LDH levels in renal tissues and (b) serum levels of vitamin E and urinary excretion
of malondialdehyde and thiobarbituric acid-reactive substances in the age-matched untreated control and EG groups and the E-treated control
and EGþ E groups.
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Figure 4 | Representative micrographs of renal sections stained
for aGST. Left panels: (a) untreated control group, (b–d) rats treated
with EG for (b) 7, (c) 21, or (d) 42 days. Right panels: (e) E-treated
control group, (f–h) rats treated with EGþ E for (f) 7, (g) 21, or
(h) 42 days. Reduced from  400.
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Figure 5 | Representative micrographs of renal sections stained
for lGST. Left panels: (a) untreated control group, (b–d) rats treated
with EG for (b) 7, (c) 21, or (d) 42 days. Right panels: (e) E-treated
control group, (f–h) rats treated with EGþ E for (f) 7, (g) 21, or
(h) 42 days. Reduced from  400.
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marker of chemically induced tubular damage, particularly in
the S3 segment of the proximal tubule.6 mGST is also a
cytosolic enzyme, and is found in the epithelial cells of the
distal tubules, as well as in the collecting ducts.6 Although
enzymuria was significantly increased in all EG subgroups,
the amount of a- and mGST in tubular cells did not show a
significant decrease until day 42 of EG treatment. Our finding
that the amount of a- and mGST in the kidneys remained
unchanged in the day 7 and 21 subgroups, despite the
increase in enzymuria, is consistent with Khan’s hypothesis13
that ‘mild to moderate hyperoxaluria and/or occasional
crystals provoke protective responses, and cause the renal
tubular cells to increase synthesis and secretion of nephro-
lithiasis modulators’.
In the EG group, PCNA-positive nuclei and PCNA levels
in the kidney were increased on day 21, but not on day 42, a
time point at which severe renal tubular damage and
increased CaOx crystal accumulation were seen. This raises
the interesting question of whether hyperoxaluria and crystal
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Figure 6 | Representative micrographs of renal tubules stained
for nuclear PCNA. PCNA-positive cells are indicated by arrows.
Left panels: (a) untreated control group, (b–d) rats treated with EG
for (b) 7, (c) 21, or (d) 42 days. Right panels: (e) E-treated control
group, (f–h) rats treated with EGþ E for (f) 7, (g) 21, or (h) 42 days.
(i) Statistical result for cell counting. *Po0.05 compared to the
corresponding control group. *Po0.05 compared to the EG group
at the same time point. Reduced from  400.
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Figure 7 | Apoptotic cells in the kidneys evaluated using TUNEL
staining. Left panels: (a) untreated control group, (b–d) rats treated
with EG for (b) 7, (c) 21, or (d) 42 days. Right panels: (e) E-treated
control group, (f–h) rats treated with EGþ E for (f) 7, (g) 21, or
(h) 42 days. (i) Statistical result for cell counting. *Po0.05 compared
to the corresponding control group. Reduced from  400.
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deposition interfere with cell proliferation, which requires
further investigation. If we calculate the cytoplasmic
cytochrome c/PCNA-positive cell ratio in the kidney in EG
rats, we find that only the ratio for the day 7 subgroup was
unchanged (3.170.5, P¼ 0.22) compared to untreated
controls (2.970.3), whereas those for the day 21 (4.770.2)
and day 42 (4.470.4) subgroups showed a significant
increase. In the EGþ E group, this ratio was unchanged in
the day 7 subgroup (0.4370.07) compared to the E-treated
controls 0.4070.03), decreased in the day 21 subgroup
7Control
-GST
-Actin
GST
-Actin -Actin
PCNA
-Actin
21
EG
42 P
7 21
Duration of treatment
42 Days 7 21
Duration of treatment
42 Days 7 21
Duration of treatment
42 Days 7 21
Duration of treatment
42 Days
7 21
Duration of treatment
42 Days7 21
Duration of treatment
42 Days7 21
Duration of treatment
42 Days7 21
Duration of treatment
42 Days
Untreated control
EG
Untreated control
EG
Untreated control
EGUntreated control
EG
EG+E
E-treated control
EG+E
E-treated control
EG+E
E-treated control
EG+E
E-treated control
7Control 21
EG
42 P
7Control
Cytochrome c
21
EG
42 P7Control 21
EG
42 P
7Control+E 21
EG+E
42 P
7Control+E 21
EG+E
42 P
7Control+E 21
EG+E
42 P
7Control+E 21
EG+E
42 P
*
*
*
*
*
*
*
*
0.0 0.0
0.5
1.0
1.5
2.0
3.0
2.5
0.0
0.5
1.0
1.5
2.0
3.0
2.5
4.0
3.5
0.0
0.5
1.0
1.5
2.0
3.0
2.5
4.0
3.5
R
ea
lti
ve
 d
en
sit
y 
of
-
G
ST
/
-
Ac
tin
0.2
0.4
0.6
0.8
1.0
0.0
R
ea
lti
ve
 d
en
sit
y 
of
G
ST
/
-
Ac
tin
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
0.0
R
ea
lti
ve
 d
en
sit
y 
of
Cy
to
ch
ro
m
e 
c/
-
Ac
tin
0.2
0.4
0.6
0.8
1.0
2.0
1.2
1.4
1.6
1.8
0.0
R
ea
lti
ve
 d
en
sit
y 
of
PC
NA
/
-
Ac
tin
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
0.0
0.2
0.4
0.6
0.8
1.0
2.0
1.2
1.4
1.6
1.8
a
b
c
d
Figure 8 | Effect of vitamin E on tubular cell death and proliferation in the EG-treated kidneys. Levels of (a) aGST, (b) mGST, and (c) PCNA,
and (d) cytochrome c release in the kidneys. The representative blots shown were obtained from two different rat kidneys. Since there was no
significant difference between control groups, one group of controls is shown. The histogram shows the relative density of the protein of
interest to b-actin for six animals in each group. EG, ethylene glycol; E, vitamin E treatment; 7, 21, and 42 represent days of administration;
P, positive control. *Po0.05 compared to the age-matched corresponding control group.
-Actin
THP
THP
OPN
Renal Medulla Urine
OPN
THP
OPN
Untreated
control
E-treated
control
EG EG+E
Untreated
control
E-treated
control
EG EG+E Untreated
control
E-treated
control
EG EG+E
P
THP
OPN44 kDa
42 kDa
80 kDa
Untreated
control
E-treated
control
EG EG+E
P
0.0 0
1000
2000
3000
4000
0
1000
2000
3000
4000
0.3
0.4
0.5R
el
at
ive
 d
en
sit
y 
un
it
R
el
at
ive
 d
en
sit
y 
un
it
0.6
0.7
1.0
2.0
3.0
4.0
5.0
*
*
*
*

*

a b
Figure 9 | Effect of vitamin E on the expressions of anticrystallization molecules in the EG-treated kidneys. Levels of osteopontin
and Tamm-Horsfall protein in the (a) renal medulla and (b) urine at day 42. The representative blots show the band for the protein
of interest in samples from three different animals. The bar graphs show the changes in OPN or THP levels in renal tissues or urine for six
animals. *Po0.05 compared to the corresponding control group. wPo0.05 compared to the EG group.
706 Kidney International (2006) 70, 699–710
o r i g i n a l a r t i c l e H-S Huang et al.: Vitamin E and renal CaOx crystals
(0.1270.02, Po0.05), and increased in the day 42 subgroup
(0.7670.12, Po0.05). These results suggest that an imbal-
ance between tubular apoptotic cell death and proliferation
might be an important factor, because vitamin E treatment
lowered this ratio by decreasing cell death, thus lowering the
number of dead cells that could act as seeds for crystal
nucleation and decreasing CaOx crystal deposition. As in our
previous study,6 the activity of antioxidant proteins in the EG
kidney was either increased (manganese superoxide dismu-
tase and catalase) or unchanged (copper/zinc superoxide
dismutase and glutathione peroxidase) after 7-day treatment,
while cell death occurs on the same day and vitamin E could
revert the changes. We therefore speculate that oxalate-
induced renal toxicity in the early stage of EG treatment is
not due to oxidative stress. Moreover, the biological
importance of vitamin E is not only limited to its role as
an antioxidant, as it also has nonantioxidant functions, such
as preventing abnormal cell proliferation in cancer and
atherosclerosis, its deficiency causes neurological disorders,
and showing an effect on genes associated with cell cycle
regulation to improve cell function.26–28 Thus, the vitamin E-
mediated prevention of cell loss in EG kidneys on day 7
might be directly dependent on the regulation of cell survival,
rather than antioxidation.
Vitamin E, the major lipid peroxidation chain-breaking
antioxidant in lipid domains, is thought to be an effective
radical scavenger and, in addition, has immunostimulatory
activity.29 In the present study, vitamin E supplementation of
EG-treated rats prevented the decrease in the amount of
a- and mGST in the nephrolithiatic kidney and the increase in
the amounts of LDH in kidney homogenates, cytochrome c
release, and the number of TUNEL-positive nuclei. Since
recycling of vitamin E from its phenoxyl radicals by
enzymatic electron transport and nonenzymatic reductants
(e.g., vitamin C, thiols) has been demonstrated,30 it is
possible that renal vitamin C levels decreased concurrently or
generated other kinds of free radicals (e.g., peroxynitrite
anion), resulting in vitamin E supplementation alone being
unable to completely eradicate the increased urinary lipid
peroxides. Further experiments are required to clarify this.
Despite the finding that vitamin E administration did not
eradicate all free radical production, renal CaOx crystal
deposits were much improved by vitamin E supplementation
in this rat model. Reckelhoff et al.31 reported that age-related
changes (oxidative stress) in the rat kidney can be partially
prevented by administration of vitamin E, while Kenkins
et al.32 reported that vitamin E can preserve renal function
and reduce levels of free radicals, vasoconstrictive thrombox-
anes, and tubulointerstitial fibrosis in a cyclosporin-induced
nephrotoxicity model in rats. In the present study, we found
that the effect of vitamin E on reducing renal CaOx deposits
might be different from that in the above study, as reduced
cell death was the major beneficial effect found after vitamin
E administration in our study. Vitamin E consists of eight
compounds, namely four tocopherols and four tocotrie-
nols.33 Tocotrienols are reported to posses certain biological
activities that are not seen with the tocopherols, including
cholesterol-lowering activity, anticancer and tumor-suppres-
sing activities, antioxidant properties, and antiblood platelet
aggregation activity;30 however, dietary sources of tocotrie-
nols and a-tocopherols result in greater serum and tissue
levels than injections.33,34 This may explain why vitamin E
supplementation by the intraperitoneal route in the present
study was unable to completely eradicate the increase in
urinary lipid peroxides and why grade I CaOx stone
formation still occurred in the EGþ E group at day 42,
contrasting with previous results in which vitamin E was
given in the food.
In this study, we evaluated whether vitamin E may have an
effect on the hyperoxaluria-induced crystal supersaturation
by calculating rat Tiselius risk index as previously proposed.35
Together with the result of urinary CaOx sediments, we
speculate that the mechanism by which vitamin E ameliorates
crystal formation is dependent on factors other than altered
urinary ion activity. However, the levels of two renal tissue
glycoproteins, OPN and THP, involved in preventing CaOx
crystal formation, were found to be increased by vitamin E
supplementation. OPN and THP are co-expressed in the
same kidney epithelial cells, but THP is kidney-specific.2,3
Khan et al.4 showed that OPN expression in renal
tissues could be increased by hyperoxaluria, whereas, in the
present study, OPN levels decreased. However, it is rational to
deduce that a hyperoxaluria-induced decrease in OPN levels
may favor CaOx crystal deposition, since this could affect
OPN-mediated cleavage of thrombin sites in protein
aggregates, which might act as nucleation seeds, and its
Arg-Gly-Asp-mediated binding to the epithelium, which
may be involved in the interaction of crystals with the
epithelium.2 In the mouse THP-knockout model, the
combination of EG and calcium overload predisposes the
kidneys to crystal formation,3 suggesting that an important
function of THP is to keep renal stones from forming, despite
levels of OPN being significantly increased in this model. Our
results show that hyperoxaluria itself can significantly
decrease THP expression in renal tissues. Interestingly, this
phenomenon was prevented by vitamin E, suggesting that the
underlying mechanism by which vitamin E reduces crystal
deposition might involve both OPN and THP. Most striking,
urinary excretion of OPN was also increased by hyperox-
aluria. This is consistent with a previous observation that
OPN is present in the matrix of stones in the urine.4
Although THP levels in the urine were not affected by
hyperoxaluria, they were still lowered by vitamin E in this
study.
In summary, tubular cell death occurred at an early stage
of hyperoxaluria at day 7 and persisted to day 42, when CaOx
crystal deposition was seen. Desquamated tubular cells in the
renal tubules may act as seeds for crystal formation. These
effects were overcome by chronic administration of vitamin
E. However, hyperoxaluria, tubular enzymuria, and urinary
lipid peroxides were not completely prevented by vitamin E.
The favorable effect of vitamin E on reducing crystal
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formation is dependent on the effect of OPN and THP in
different compartments of the urinary system.
MATERIALS AND METHODS
Male Wistar rats (200–250 g) were housed at a constant temperature
on a light/dark cycle (light from 0700 to 1800). All animal
experiments and animal care were performed in accordance with
the Guide for the Care and Use of Laboratory Animals (National
Research Council, 1996).
Experimental induction of renal CaOx crystal and vitamin E
treatment
The rats were divided into four groups of 24 animals. The two
control groups were given distilled water to drink and two
intraperitoneal injections a week of either vitamin E (200 mg kg1,
ICN Biomedicals, Aurora, OH, USA) in olive oil (E-treated control
group) or the same volume of vehicle (untreated control group).
The two test groups were given 0.75% EG in distilled water to drink
so as to induce hyperoxaluria as described previously5,6,36 and were
injected as above, giving the EGþ E group and the EG group. Each
group consisted of three subgroups of eight animals that were
treated as above for 7, 21, or 42 days. The animals were placed in
metabolic cages 3 days before the beginning of the experiment to
allow them to acclimatize. During the experimentation period, all
groups had free access to ground rat chow (PMI Nutrition
International, Purina Mills, Inc., USA, containing less than
33 mg kg1 of vitamin E) and drinking water with or without EG
as above.
Urinary biochemistry
Urine samples were collected 24 h before killing, and were
centrifuged at 2000 g for 10 min to remove debris. The debris was
collected to examine the presence of CaOx crystals in urine
sediments by polarized microscopy as following and weighed before
placement in an oven for 48 to 72 h. The sediments were weighed
daily until the dry weight was stable. The supernatants were used to
determine the urinary pH and levels of oxalate, creatinine (Cr),
calcium (Ca), phosphate (P), magnesium (Mg), and citrate at the
central laboratory of the National Taiwan University Hospital as
described previously.5,6,36 Urinary supersaturation with respect to
CaOx was assessed by using the index proposed by Tiselius et al.,35
where the ion activity product is estimated by following formula:
(4076 (Ca)0.93 (Oxalate)0.96)/((Citrateþ 0.015)0.60 (Mg)0.55
 (V)0.99). Urinary Ca, oxalate, citrate, and Mg are expressed in
millimoles per 24 h urine volume (V) in liters for the calculation.
Determination of enzymuria
Urinary N-acetyl-b-glucosaminidase was measured using our
previous method,36 modified from that of Maruhn1 In brief,
10 mmol/l 4-nitrophenyl-N-acetyl-b-D-glucosaminidase (Calbio-
chem Corp. La Jolla, CA, USA) in 0.1 mol/l citrate buffer, pH 4.2,
was used as buffer-substrate solution. Each urine sample (0.2 ml)
was added to a tube containing an equal volume of buffer-substrate
solution, then the tubes were incubated in a water-bath at 371C for
15 min. Reagent blanks (physiological saline instead of urine) and
sample blanks (buffer plus urine) were incubated simultaneously.
The reaction was terminated by addition of 0.2 ml of 0.75 mM
2-amino-2-methyl-propan-1-ol/HCl, then the amount of liberated
4-nitrophenol was measured photometrically at 405 nm within
30 min.
Determination of oxalauria and urinary lipid peroxides
The urinary oxalate level was assayed with a commercial oxalate kit
(Sigma, St Louis, MO, USA). Urinary lipid peroxide was examined
by measuring thiobarbituric acid-reactive substances with an Oxi-
tek thiobarbituric acid-reactive substances Assay Kit (Zepto-Metrix,
Buffalo, NY, USA), and malondialdehyde with a Bioxytechmda-586
(OxisResearch, Portland, OR, USA). All assays were performed in
duplicate and the results expressed per gram or milligrams of
urinary creatinine as described previously.36
Measurement of serum vitamin E
A modification of the method of Augustin et al.,37 which has proved
to be useful for analyzing levels of vitamin E in either serum or
plasma specimens,37,38 was used. This method is based on the ferric
chloride oxidation of tocopherols extracted from the blood sample
by xylene, the pink complex formed between ferrous ions and
bathophenanthroline being measured colorimetrically at 536 nm.
Each sample was assayed in duplicate.
Preparation of renal sections for crystal examination
The kidney was perfused by a transcardiac method with cold
phosphate-buffered saline (0.1 M PBS, pH 7.4) as described
previously5,6,36 and postfixed overnight in 4% formalin solution
containing 5% zinc sulfate, then 5 mm thick sections were prepared.
The sections were then stained with hematoxylin–eosin. Crystal
deposits were clearly visible under an Olympus BH-2 polarizing
microscope. Each kidney was scored semiquantitatively as one of
four grades (0, I, II, III), ranging from ‘no’ (0) to ‘massive’ (III)
crystal deposit, as described previously.6,35
Immunohistochemistry
Kidney sections, prepared as described above, were deparaffinized
with Lemozol (WAKO, Tokyo, Japan), rehydrated, and washed three
times in 0.1 M PBS. Endogenous peroxidase was blocked by
incubation at room temperature for 30 min with 0.3% H2O2/
methanol, then, after washing in PBS, the sections were blocked by
incubation for 1 h with 1% bovine serum albumin (Sigma, St Louis,
USA) in PBS.
To detect a- and mGST, the sections were incubated successively
for 1 h at room temperature with rabbit polyclonal antiserum
against human aGST or mGST (Biogenesis, England, UK) diluted
200-fold in blocking solution and biotinylated goat anti-rabbit IgG
antibodies diluted 1:200 in blocking solution. Bound antibody was
visualized using a commercial diaminobenzidine peroxidase sub-
strate kit (Vector, Burlingame, CA, USA), and the sections
counterstained with 10% hematoxylin. aGST- and mGST-positive
cells were counted in 10 HPF at  400 magnification, as previously
described by Miyajima et al.39
The same procedure was used to detect PCNA. The primary
antibody was mouse monoclonal antibody (Biocarta, San Diego,
CA, USA), diluted 200-fold, and the second antibody biotinylated
anti-mouse IgG antibody (Vector), diluted 200-fold; other details
were as above.
Determination of aGST, lGST, PCNA, Cytochrome c release,
OPN, and THP in kidney fractions
aGST, mGST, PCNA, OPN, and THP levels and cytochrome c release
in the kidneys were examined using Western blots as our previous
method,40 the positive controls being liver for aGST, OPN, and
cytochrome c, testis for mGST, and small intestine for PCNA. All
procedures were performed at 41C unless otherwise specified. The
samples used for aGST, mGST, PCNA, OPN, and THP estimates
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were total protein samples prepared by homogenizing the tissue in
PBS containing protease inhibitor cocktail (1mM pepstatin, 200 mM
phenylmethylsulfonyl fluoride, 1 mM leupeptin, and 1 mM ethylene-
diaminetetraacetic acid; Roche, Mannheim, Germany) and centri-
fuging the homogenate at 620 g for 10 min to remove cellular debris,
while, to measure cytochrome c release, a cytosolic fraction was
prepared by further centrifugation at 1500 g for 20 min. Protein
concentrations were measured using a Bio-Rad Dc protein assay kit
(Hercules, CA, USA). The same amount of protein from each
preparation (100mg for aGST and mGST, 20mg for cytochrome c,
OPN, and THP, and 50 mg for PCNA) was separated on SDS
polyacrylamide gels (7% for GST and 12% for others), and
electrophoretically transferred onto nitrocellulose membranes
(Amersham, Buckingham, England, UK). After blocking for 1 h at
room temperature with 5% milk in Tris-buffered saline, pH 7.4, the
membrane was incubated overnight with rabbit polyclonal anti-
bodies against aGST (1:200; Biogenesis, England, UK), mGST
(Biogenesis, England, UK), cytochrome c (1:1000; BioVision, CA,
USA), PCNA (1:500; Biocarta, San Diego, CA, USA), or b-actin
(1:1000; Sigma, MO, USA), or monoclonal mouse antibodies against
human OPN or THP (both from Cedarlane, Ontario, Canada) in
blocking solution. After washes in Tris-buffered saline containing
0.1% Tween-20, it was then incubated for 1 h at room temperature
with biotinylated goat anti-rabbit or anti-mouse IgG antibodies
(Vector, Burlingame, CA, USA). The densities of the bands for aGST
(26 kDa), mGST (27 kDa), PCNA (36 kDa), cytochrome c (12 kDa),
OPN (44 kDa), and THP (80 kDa) were determined semiquantita-
tively on a densitometer with an image analytic system (Alpha
Innotech, San Leandro, CA, USA) and expressed relative to that for
b-actin.
Evaluation of apoptosis
In situ detection of renal tubular cells with DNA-strand breaks in
renal sections was performed using the TUNEL method, using a
TdT-FragELTM kit (Oncogene, Boston, MA, USA) following the
manufacturer’s protocol. Negative controls were performed by
substituting distilled water for the TdT enzyme. To quantify the
incidence of apoptosis in each subgroup, the number of TUNEL-
positive cell nuclei was calculated. Ten areas (at  400) in each
preparation were counted separately, and the mean of these 10
counts taken as the final result.
Statistical analyses
Numerical data are presented as the mean7s.e.m. Differences
between groups were analyzed using an unpaired t-test or one-way
analysis of variance, and Duncan’s multiple-range test was used to
find differences that were significant at the level of Po0.05.
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